These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16320975)

  • 61. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.
    Sitbon O; Humbert M; Nunes H; Parent F; Garcia G; Hervé P; Rainisio M; Simonneau G
    J Am Coll Cardiol; 2002 Aug; 40(4):780-8. PubMed ID: 12204511
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Central venous blood oxygen saturation monitoring in patients with chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with measurements of hemodynamics and plasma brain natriuretic peptide levels.
    Chin KM; Channick RN; Kim NH; Rubin LJ
    Chest; 2007 Sep; 132(3):786-92. PubMed ID: 17646224
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Pregnancy outcome in women with rheumatic heart disease].
    Lin JH; Ling WW; Liang AJ
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):315-9. PubMed ID: 17673043
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Subcutaneous implantation of a new intravenous pump system for prostacyclin treatment in patients with pulmonary arterial hypertension.
    Desole S; Velik-Salchner C; Fraedrich G; Ewert R; Kähler CM
    Heart Lung; 2012; 41(6):599-605. PubMed ID: 22920608
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of aerobic or aerobic and resistance training on cardiorespiratory and skeletal muscle function in heart failure: a randomized controlled pilot trial.
    Mandic S; Tymchak W; Kim D; Daub B; Quinney HA; Taylor D; Al-Kurtass S; Haykowsky MJ
    Clin Rehabil; 2009 Mar; 23(3):207-16. PubMed ID: 19218296
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.
    Aguilar RV; Farber HW
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1846-50. PubMed ID: 11069824
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical observation of cardiopulmonary exercise test in patients with idiopathic pulmonary arterial hypertension].
    Luo Q; Liu ZH; Ma XP; Zhao ZH; Gu Q; Xiong CM; Ni XH; He JG; Zhao Q
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(22):1683-6. PubMed ID: 24124671
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of continuous intravenous epoprostenol therapy on advanced primary pulmonary hypertension in Taiwanese patients.
    Hsu HH; Chen JS; Kuo SH; Chiang FT; Ko WJ; Kuo SW; Huang SC; Lee YC
    J Formos Med Assoc; 2005 Jan; 104(1):60-3. PubMed ID: 15660181
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treprostinil for pulmonary hypertension.
    Vachiéry JL; Naeije R
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):183-91. PubMed ID: 15151467
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Initial and programmed combination therapy with oral drugs for severe idiopathic pulmonary arterial hypertension.
    Maki H; Yao A; Inaba T; Shiga T; Hatano M; Kinugawa K; Yamashita T; Aizawa T; Nagai R
    Int Heart J; 2011; 52(5):323-6. PubMed ID: 22008445
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue.
    Vizza CD; Sciomer S; Morelli S; Lavalle C; Di Marzio P; Padovani D; Badagliacca R; Vestri AR; Naeije R; Fedele F
    Heart; 2001 Dec; 86(6):661-5. PubMed ID: 11711462
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Continuous intravenous prostacyclin therapy].
    Miyaji K; Matsubara H
    Nihon Rinsho; 2008 Nov; 66(11):2139-44. PubMed ID: 19051733
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Atrial septal defect closure in a patient with "irreversible" pulmonary hypertensive arteriopathy.
    Schwerzmann M; Zafar M; McLaughlin PR; Chamberlain DW; Webb G; Granton J
    Int J Cardiol; 2006 Jun; 110(1):104-7. PubMed ID: 15992947
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension.
    Nagaya N; Sasaki N; Ando M; Ogino H; Sakamaki F; Kyotani S; Nakanishi N
    Chest; 2003 Feb; 123(2):338-43. PubMed ID: 12576349
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetic evaluation of continuous intravenous epoprostenol.
    Chaumais MC; Jobard M; Huertas A; Vignand-Courtin C; Humbert M; Sitbon O; Rieutord A; Montani D
    Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1587-98. PubMed ID: 21077785
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Plasma brain natriuretic peptide as a parameter to assess efficacy of continuous intravenous infusion of prostacyclin (epoprostenol) to treat severe primary pulmonary hypertension: a case report.
    Wakaumi M; Shiga T; Nozaki K; Fujiu K; Shimaya K; Ishizuka N; Matsuda N; Kasanuki H
    Heart Vessels; 2000; 15(3):144-6. PubMed ID: 11289503
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rapid and high-dose titration of epoprostenol improves pulmonary hemodynamics and clinical outcomes in patients with idiopathic and heritable pulmonary arterial hypertension.
    Tokunaga N; Ogawa A; Ito H; Matsubara H
    J Cardiol; 2016 Dec; 68(6):542-547. PubMed ID: 27005767
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects.
    Rosenzweig EB; Kerstein D; Barst RJ
    Circulation; 1999 Apr; 99(14):1858-65. PubMed ID: 10199883
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertension.
    Wax D; Garofano R; Barst RJ
    Chest; 1999 Oct; 116(4):914-20. PubMed ID: 10531153
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Evaluation of visceral impairments by exercise testing: practice and problems in recently-developed exercise testing in disabled patients and an introduction of a newly-developed instrument for monitoring cardiopulmonary and postural parameters].
    Kohzuki M; Goto Y; Yoshida T; Sasaki M; Watanabe M; Yoshida K; Sato T
    Rinsho Byori; 1999 Dec; 47(12):1149-58. PubMed ID: 10639825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.